EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2020. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,121,000 | -86.2% | 53,396 | -79.6% | 0.06% | -83.4% |
Q2 2022 | $8,118,000 | -34.7% | 261,533 | -13.6% | 0.39% | -20.8% |
Q1 2022 | $12,430,000 | -16.7% | 302,721 | -11.8% | 0.50% | -6.6% |
Q4 2021 | $14,925,000 | -19.8% | 343,347 | -7.7% | 0.53% | -23.0% |
Q3 2021 | $18,620,000 | -27.4% | 371,888 | -8.7% | 0.69% | -24.6% |
Q2 2021 | $25,659,000 | -45.3% | 407,347 | -19.3% | 0.91% | -40.3% |
Q1 2021 | $46,906,000 | -10.9% | 504,858 | -14.1% | 1.53% | -17.5% |
Q4 2020 | $52,660,000 | -18.2% | 587,727 | -5.7% | 1.85% | -28.6% |
Q3 2020 | $64,388,000 | +22.9% | 623,132 | -5.9% | 2.60% | +15.4% |
Q2 2020 | $52,379,000 | +18.3% | 662,349 | -13.4% | 2.25% | -9.1% |
Q1 2020 | $44,275,000 | -25.4% | 765,202 | -30.5% | 2.47% | +23.1% |
Q4 2019 | $59,386,000 | -7.6% | 1,100,765 | -10.4% | 2.01% | -12.5% |
Q3 2019 | $64,241,000 | +10.5% | 1,228,791 | +2.1% | 2.30% | +18.8% |
Q2 2019 | $58,149,000 | -5.7% | 1,203,666 | -1.4% | 1.93% | -2.7% |
Q1 2019 | $61,657,000 | -23.3% | 1,220,454 | -10.0% | 1.98% | -32.3% |
Q4 2018 | $80,381,000 | +9.4% | 1,355,949 | +21.5% | 2.93% | +11.5% |
Q3 2018 | $73,458,000 | +27.5% | 1,115,875 | -2.2% | 2.63% | +25.5% |
Q2 2018 | $57,610,000 | +13.2% | 1,141,021 | +18.1% | 2.10% | +5.5% |
Q1 2018 | $50,881,000 | +42.4% | 966,407 | +25.7% | 1.99% | +41.4% |
Q4 2017 | $35,740,000 | +37.4% | 769,096 | +19.6% | 1.40% | +22.1% |
Q3 2017 | $26,010,000 | +14.5% | 643,027 | -4.0% | 1.15% | +16.6% |
Q2 2017 | $22,707,000 | +47.3% | 669,617 | +26.1% | 0.99% | +31.4% |
Q1 2017 | $15,420,000 | +20.4% | 531,006 | +36.1% | 0.75% | +16.3% |
Q4 2016 | $12,811,000 | +29.1% | 390,100 | +24.0% | 0.65% | +24.5% |
Q3 2016 | $9,921,000 | +26.3% | 314,645 | +12.7% | 0.52% | +14.8% |
Q2 2016 | $7,852,000 | -21.5% | 279,227 | +1.4% | 0.45% | -21.8% |
Q1 2016 | $10,007,000 | -7.2% | 275,297 | +2.1% | 0.58% | -6.2% |
Q4 2015 | $10,785,000 | +144.4% | 269,551 | +74.1% | 0.62% | +115.4% |
Q3 2015 | $4,412,000 | +45.2% | 154,850 | +67.9% | 0.29% | +62.5% |
Q2 2015 | $3,039,000 | – | 92,220 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |